Study: Lifetime Cost of Vyjuvek Gene Therapy for DEB Could Be $15-$22 MillionFebruary 9, 2024PediatricsRare DiseasesDermatologyWoundsBusiness of Medicine
FDA Approves Topical Gel For Wounds Associated With JEB and DEBDecember 22, 2023Rare DiseasesPediatricsWoundsDermatology
New consensus guide on rare drug hypersensitivity reactionNovember 29, 2023Medical DermatologyWoundsNeurologyDermatologyEpilepsy & SeizuresMixed Topics
More phase 3 data support use of nemolizumab for prurigo nodularisNovember 2, 2023Medical DermatologyWoundsRare DiseasesDermatology
Birch bark–derived treatment reduces daily dressings in patients with epidermolysis bullosaNovember 2, 2023WoundsPediatricsRare DiseasesDermatology
Novel hydrogel holds promise for skin regenerationOctober 31, 2023WoundsDermatologic SurgeryDermatology
Hyperbaric oxygen therapy beneficial for calciphylaxis?September 14, 2023WoundsMedical DermatologyDermatology
A White male presented with a purulent erythematous edematous plaque with central necrosis and ulceration on his right flankSeptember 12, 2023Infectious DiseasesWoundsDermatology
New AI-enhanced bandages poised to transform wound treatmentSeptember 7, 2023WoundsDermatologyInfectious Diseases
Skin has different daytime and nighttime needs, emerging circadian research suggestsSeptember 7, 2023Aesthetic DermatologyWounds
Progress seen on five fronts for substantially improving treatment of epidermolysis bullosaJuly 27, 2023PediatricsRare DiseasesWoundsDermatology
‘New standard of care’ for capecitabine hand-foot syndromeJune 15, 2023Mixed TopicsGastrointestinal CancerWoundsBreast Cancer